These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 16378663

  • 1. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S, Iwatsuki-Horimoto K, Ito M, Tagawa-Sakai Y, Yamada S, Ito H, Ito T, Imai M, Itamura S, Odagiri T, Tashiro M, Lim W, Guan Y, Peiris M, Kawaoka Y.
    Vaccine; 2006 Apr 24; 24(17):3669-76. PubMed ID: 16378663
    [Abstract] [Full Text] [Related]

  • 2. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.
    Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M.
    J Infect Dis; 1999 May 16; 179(5):1132-8. PubMed ID: 10191214
    [Abstract] [Full Text] [Related]

  • 5. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Varich NL, Ilyushina NA, Gambaryan AS, Krylov PS, Kaverin NV.
    Arch Virol; 2007 May 16; 152(6):1139-45. PubMed ID: 17294090
    [Abstract] [Full Text] [Related]

  • 6. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M, de Jonge J, Laue M, Wolff T.
    Vaccine; 2011 Jul 18; 29(32):5153-62. PubMed ID: 21624413
    [Abstract] [Full Text] [Related]

  • 7. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

  • 8. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
    Lu JH, Long JX, Jia LJ, Liu YL, Shao WX, Zhang YM, Liu XF.
    Acta Virol; 2006 Jan 29; 50(4):243-9. PubMed ID: 17177609
    [Abstract] [Full Text] [Related]

  • 9. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W, Dong Z, Meng W, Zhang W, Li T, Li C, Zhang B, Chen L.
    Hum Vaccin Immunother; 2012 Feb 29; 8(2):252-9. PubMed ID: 22426370
    [Abstract] [Full Text] [Related]

  • 10. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC.
    Vaccine; 2008 May 02; 26(19):2307-13. PubMed ID: 18395947
    [Abstract] [Full Text] [Related]

  • 11. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
    Li C, Ping J, Jing B, Deng G, Jiang Y, Li Y, Tian G, Yu K, Bu Z, Chen H.
    Biochem Biophys Res Commun; 2008 Jul 25; 372(2):293-7. PubMed ID: 18501701
    [Abstract] [Full Text] [Related]

  • 12. Antigenic and genetic analysis of H5 influenza viruses isolated from water birds for the purpose of vaccine use.
    Soda K, Ozaki H, Sakoda Y, Isoda N, Haraguchi Y, Sakabe S, Kuboki N, Kishida N, Takada A, Kida H.
    Arch Virol; 2008 Jul 25; 153(11):2041-8. PubMed ID: 18932020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
    Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, Chichester JA, Mett V, Yusibov V.
    Vaccine; 2009 May 26; 27(25-26):3467-70. PubMed ID: 19200814
    [Abstract] [Full Text] [Related]

  • 16. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.
    Vaccine; 2008 Mar 25; 26(14):1742-50. PubMed ID: 18336962
    [Abstract] [Full Text] [Related]

  • 17. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.
    Vaccine; 2008 Oct 03; 26(42):5393-9. PubMed ID: 18706956
    [Abstract] [Full Text] [Related]

  • 18. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB, Buonocore L, Vogel L, Nachbagauer R, Krammer F, Rose JK.
    J Virol; 2015 Mar 03; 89(5):2820-30. PubMed ID: 25540378
    [Abstract] [Full Text] [Related]

  • 19. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.
    Vaccine; 2006 Nov 17; 24(47-48):6859-66. PubMed ID: 17050041
    [Abstract] [Full Text] [Related]

  • 20. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W, Xue T, Wu X, Zhang P, Zhao G, Peng D, Hu S, Wang X, Liu X, Liu W, Liu X.
    Vaccine; 2011 Oct 19; 29(45):8032-41. PubMed ID: 21864614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.